Pharma Journalist -

Bloom Science, a biopharmaceutical company developing microbiome-derived therapeutics in multiple neurological conditions and oncology, announced the launch of a research agreement with…
Read More...

LEO Pharma A/S announced that tralokinumab – an investigational, fully human monoclonal antibody that specifically neutralizes the interleukin-13 (IL-13) cytokine – met all primary and…
Read More...

AbbVie, a research-based global biopharmaceutical company and Scripps Research, an international leader in non-profit biomedical research and drug discovery, announced a collaboration…
Read More...

Merck, known as MSD outside the United States and Canada, and ArQule, Inc. announced that the companies have entered into a definitive agreement under which Merck, through a subsidiary,…
Read More...

Healx Ltd., the AI-powered biotechnology company focused on developing breakthrough treatments for rare diseases, announces it has entered into an agreement with Boehringer Ingelheim to…
Read More...

Sanofi and Synthorx, a clinical-stage biotechnology company focused on prolonging and improving the lives of people suffering from cancer and autoimmune disorders, entered into a…
Read More...

The Incheon Metropolitan City government announced an ambitious plan for developing the Songdo Global Biotech Cluster in the Incheon Free Economic Zone. Aiming to attract global…
Read More...

Avitide, Inc., the industry leader in the discovery and development of custom affinity purification resins, announces that it has entered into an exclusive license agreement to support…
Read More...

MetP Pharma AG announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for its patent entitled “Treatment of Demyelinating…
Read More...

Amgen announced that the U.S. Food and Drug Administration (FDA) has approved AVSOLA (infliximab-axxq) for all approved indications of the reference product, Remicade (infliximab): for…
Read More...